• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

maladie de Charcot

Images tagged "maladie-de-charcot"

Michel Perrozzo, France

[Show as slideshow]

Primary Sidebar

  • Ywan Dierick, Belgium

    Ywan Dierick, Belgium

  • Dr. Shelly Hoover, USA

    Dr. Shelly Hoover, USA

  • Maurice Leclerc, Canada

    Maurice Leclerc, Canada

  • Jo Knowlton, Scotland

    Jo Knowlton, Scotland

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Jack Buzby, USA

    Jack Buzby, USA

  • Susan Keldani, USA

    Susan Keldani, USA

  • Rudiger Hanemann, Germany

    Rudiger Hanemann, Germany

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Dr. Janmejay Pradhan, India

    Dr. Janmejay Pradhan, India

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • JP

    JP

  • Liz Ogg, Scotland

    Liz Ogg, Scotland

  • Paul Launer, USA

    Paul Launer, USA

  • Lin Yong Yi, Taiwan

    Lin Yong Yi, Taiwan

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Elkin Ramiro Gaviria Muñoz, Colombia

    Elkin Ramiro Gaviria Muñoz, Colombia

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Jon Newsome, USA

    Jon Newsome, USA

  • Animesh Kumar, India

    Animesh Kumar, India

  • Steve

    Steve

  • Sam Hayden-Harler, UK

    Sam Hayden-Harler, UK

  • Ching-Liang Chu, Taiwan

    Ching-Liang Chu, Taiwan

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Gisli Jonasson, Iceland

    Gisli Jonasson, Iceland

  • Shaleen Latchman, Canada

    Shaleen Latchman, Canada

  • Olga, Argentina

    Olga, Argentina

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Mirca Bersani, Italy

    Mirca Bersani, Italy
    MircaBersani

  • Claire Garry, USA

    Claire Garry, USA
    20200117_214643

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

  • Enzo Maccarrone, Italy

    Enzo Maccarrone, Italy

  • David Hall, USA

    David Hall, USA

  • Mike Cels, Canada

    Mike Cels, Canada

  • Francisco Perez Palop, Spain

    Francisco Perez Palop, Spain

  • Ali Var, Turkey

    Ali Var, Turkey

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Calum Ferguson, Scotland

    Calum Ferguson, Scotland

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login